Multicenter, Prospective, Randomized, Controlled, Double-blind Trial on the Impact of Rosuvastatin on Subclinical Markers of Atherosclerosis in Patients With Primary Necrotizing Vasculitides

Name: Multicenter, Prospective, Randomized, Controlled, Double-blind Trial on the Impact of Rosuvastatin on Subclinical Markers of Atherosclerosis in Patients With Primary Necrotizing Vasculitides
Published: 2014
License: Public Domain

Assistance Publique - Hôpitaux de Paris · 2014

ClinicalTrials.gov · Datasets · License: Public Domain · 2014

Open Source ↗

death myocardial-infarction stroke

anca-associated primary necrotizing vasculitides, anca vasculitis, statin, subclinical markers of atherosclerosis, cardiovascular events, myocardial infarction, stroke, arterial revascularization, unstable angina, death, interventional, phase3

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Multicenter, Prospective, Randomized, Controlled, Double-blind Trial on the Impact of Rosuvastatin on Subclinical Markers of Atherosclerosis in Patients With Primary Necrotizing Vasculitides

Related documents